Barclays PLC Esperion Therapeutics, Inc. Put Options Transaction History

Barclays PLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2019 Feb 10, 2020	SELL	$35.4 - $59.82 $67,260 - $113,658	-1,900 Reduced 65.52%	1,000 $60,000
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $72,180 - $94,194	1,800 Added 163.64%	2,900 $135,000
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $16,044 - $21,428	-400 Reduced 26.67%	1,100 $44,000
Q4 2018 Feb 14, 2019	SELL	$36.99 - $59.11 $895,158 - $1.43 Million	-24,200 Reduced 94.16%	1,500 $69,000
Q3 2018 Nov 14, 2018	BUY	$40.74 - $51.41 $73,332 - $92,538	1,800 Added 7.53%	25,700 $1.14 Million
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $850,700 - $1.8 Million	23,500 Added 5875.0%	23,900 $937,000
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $19,782 - $24,228	300 Added 300.0%	400 $29,000
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $4,380 - $5,277	100	100 $5,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.